Safety, efficacy, and duration of effect of a new Botulinum Neurotoxin Type A preparation free of complexing proteins

被引：0

|

作者：

Wohlfarth, K

Mueller, C

机构：

来源：

MOVEMENT DISORDERS | 2005年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P35

引用

收藏

页码：S11 / S11

页数：1

相关论文

共 50 条

[1] Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins
Oh, Hyun-Mi
Park, Joo Hyun
Song, Dae Heon
Chung, Myung Eun
TOXINS, 2016, 8 (01):
[2] Stability of Xeomin®, a preparation of botulinum neurotoxin type A, free of complexing proteins
Grein, S.
Mander, G. J.
Grafe, S.
MOVEMENT DISORDERS, 2007, 22 : S18 - S18
[3] Efficacy and safety of botulinum neurotoxin type A free of complexing proteins (NT 201) in cervical dystonia and blepharospasm
Jost, Wolfgang H.
FUTURE NEUROLOGY, 2007, 2 (05) : 485 - 493
[4] Efficacy and Safety of NT 201 (Botulinum Neurotoxin Free from Complexing Proteins) in Blepharospasm
Jankovic, Joseph
Comella, Cynthia
Hanschmann, Angelika
Grafe, Susanne
NEUROLOGY, 2009, 72 (11) : A346 - A346
[5] Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
Roggenkämper, P
Jost, WH
Bihari, K
Comes, G
Grafe, S
JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (03) : 303 - 312
[6] Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
P. Roggenkämper
W. H. Jost
K. Bihari
G. Comes
S. Grafe
Journal of Neural Transmission, 2006, 113 : 303 - 312
[7] Safety and efficacy of repeated NT 201 (botulinum neurotoxin type A free from complexing proteins) injections of patients with blepharospasm
Grafe, S.
Hanschmann, A.
Jankovic, J.
Comella, C.
MOVEMENT DISORDERS, 2010, 25 (07) : S235 - S236
[8] Efficacy and safety of a new botulinum toxin type A free of complexing proteins in treatment of cervical dystonia
Benecke, R
MOVEMENT DISORDERS, 2004, 19 : S110 - S111
[9] Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN®) in Focal Dystonia
Wolfgang H. Jost
Jörg Blümel
Susanne Grafe
Drugs, 2007, 67 : 669 - 683
[10] Botulinum neurotoxin type A free of complexing proteins (XEOMIN®) in focal dystonia
Jost, Wolfgang H.
Bluemel, Joerg
Grafe, Susanne
DRUGS, 2007, 67 (05) : 669 - 683

← 1 2 3 4 5 →